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A large number of pyrimidine derivatives are reported to exhibit antimycobacterial
(1), antitumor (2), antiviral (3), anticancer (4), anti-inflammatory (4), analgesic (4), an-
tifolate (5), antimicrobial (6), anti-fungal (7), antiproliferative (8) and antihistaminic (9)
activities. They are also effective as antiplatelet agents with analgesic activity (10) and as
a new drug for treatment of insomnia (11).
In view of these reports and as continuation of our recent studies (12, 13), the syn-
theses of a new series of compounds containing the pyrimidine moiety are now repor-
ted. The one-pot reaction of 2-(2,4-dinitrophenyl)-5-methyl-2,4-dihydro-3H-pyrazol-3-
one (1), p-methoxybenzaldehyde, malononitrile in the presence of ammonium acetate or
piperidine afforded the bifunctional compounds 2 and 3, which are used as key interme-
diates for the preparation of pyrimidine derivatives in their reactions with formic acid,
formamide-formic acid-dimethylformamide, ammonium thiocyanate in acetic acid and
triethyl orthoformate, followed by cyclization with hydrazine hydrate. Several com-
pounds were screened for their antimicrobial activity.
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The bifunctional pyrazolopyridine (2) and pyrano-pyra-
zole (3) derivatives were prepared by the reaction of 2-
-(2,4-dinitrophenyl)-5-methyl-2,4-dihydro-3H-pyrazol-3-
one (1) with p-methoxybenzaldehyde, malononitrile in
the presence of ammonium acetate or piperidine, respec-
tively. Compound 2 was used as the key intermediate to
prepare the pyrazolo-pyrido-pyrimidine derivatives
through its reaction with formic acid, formamide-formic
acid-DMF, ammonium thiocyanate or reaction with tri-
ethyl orthoformate followed by cyclization with hydra-
zine hydrate. Reaction of 3 with triethyl orthoformate
followed by cyclization with hydrazine hydrate gave the
pyrazolo-pyrano-pyrimidine derivative 11. Reaction of
ethyl-3-oxo-2-2-phenyl-diazenylbutanoate and ethyl 2-
-2-(4-chlorophenyl)diazenyl-3-oxobutanoate with 1 to
give the pyrazolone derivatives 13a and 13b, was also
considered.
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EXPERIMENTAL
All melting points are uncorrected. IR spectra (KBr) were recorded with a Shimadzu
FT-IR 8201 PC spectrophotometer (Shimadzu, Japan). 1H NMR were measured with a
Varian UN 1009 S-60 T instrument (Varian-USA) using TMS as internal standard and
mass spectra were measured with a Shimadzu GCMS-QP 100 EX mass spectrometer.
Synthesis of 6-amino-1-(2,4-dinitrophenyl)-4-(4-methoxyphenyl)-3-methyl-1H-
-pyrazolo3,4-bpyridine-5-carbonitrile (2), 6-amino-1-(2,4-dinitrophenyl)-4-(4-
-methoxyphenyl)-3-methyl-1,4-dihydropyrano 2,3-cpyrazole-5-carbonitrile (3) and
1-(2,4-dinitrophenyl)-4-(4-methoxyphenyl)-3,6-dimethyl-1H-pyrazolo3,4-bpyridine (9)
To a mixture of 2-(2,4-dinitrophenyl)-5-methyl-2,4-dihydro-3H-pyrazol-3-one (1)
(0.01 mol), p-methoxybenzaldehyde (0.01 mol), malononitrile (0.01 mol) or ethyl ace-
toacetate (0.01 mol), ammonium acetate (0.03 mol) or a few drops of piperidine was
added. The mixture was heated at 190 C for 15 h. After cooling, the obtained solid was
washed with water, dried and crystallized from butanol (products 2 and 9) or ethanol
(product 3).
Compound 2. – m.p. 228 C. IR(KBr): max 2206 (CN) and 1623 cm–1 (C=N) cm–1.
1H NMR (DMSO-d6),  (ppm): 8.87–7.04 (7H, m, Ar-H), 3.33 (3H, s, OCH3), 2.50 (3H, s,
CH3). Analysis of C21H15N7O5 (%): calcd. C 56.63, H 3.37, N 22.02; found C 56.36, H 3.58,
N 21.80. Mass spectrum: ion peak at m/z 445 (6.52%).
Compound 9. – m.p. 235 C. IR(KBr): max 1730 (CO), 1618 (C=N) cm–1. 1H NMR
(DMSO-d6),  (ppm): 8.86–7.73 (7H, m, Ar-H), 7.06 (1H, s, =CH), 3.33 (3H, s, OCH3), 2.51
(3H, s, CH3), 2.50 (3H, s, CH3). Analysis for C21H16N6O6 (%): calcd. C 56.25, H 3.57, N
18.75; found C 56.47, H 3.63, N 18.88. Mass spectrum: ion peak at m/z at 419 (100%).
Compound 3. – m.p. 160 C. IR(KBr): max 2218 (CN) and 1619 (C=N) cm–1. 1H NMR
(DMSO-d6), (ppm): 8.83–7.15 (7H, m, Ar-H), 3.88 (1H, s, -CH pyran), 3.36 (3H, s, OCH3),
2.50 (3H, s, CH3). Analysis for C21H17N5O5 (%): calcd. C 60.14, H 4.06, N 16.71; found C
60.35, H 3.97, N 16.43.
Synthesis of 1-(2,4-dinitrophenyl)-4-(4-methoxyphenyl)-3-methyl-1,8-dihydro-5H-
-pyrazolo4’,3’:5,6pyrido2,3-dpyrimidin-5-one (4)
A solution of 2 (0.01 mol) and formic acid (10 mL) was refluxed for 10 h. The solvent
was removed under reduced pressure and the separated solid was recrystallized from
ethanol to give 4.
m.p. 273 C. IR(KBr): max 3240 (NH), 1685 (CO) and 1620 (C=N) cm–1. 1H NMR
(DMSO-d6), (ppm): 8.58 (1H, s, CH pyrimidine), 7.96–7.21 (7H, m, Ar-H), 3.71 (3H, s,
OCH3), 2.34 (3H, s, CH3). Analysis of C22H15N7O6 (%): calcd. C 55.81, H 3.17, N 20.72;
found C 55.68, H 3.32, N 20.58.
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Synthesis of 1-(2,4-dinitrophenyl)-4-(4-methoxyphenyl)-3-methyl-1H-pyrazolo-
-4’,3’:5,6pyrido2,3-dpyrimidin-5-amine (5)
To a mixture of formamide (10 mL), formic acid (5 mL) and dimethyl formamide
(5 mL), compound 2 (0.01 mol) was added and the reaction mixture was refluxed for
12 h. The solid that separated on cooling was filtered off and purified by boiling several
times with ethanol to give 5.
m.p. 328 C. IR(KBr): max 3370 (NH) and 1622 (C=N) cm–1. Analysis for C22H16N8O5
(%): calcd. C 55.93, H 3.39, N 23.73; found C 56.23, H 3.21, N 23.54.
Synthesis of N-1-(2,4-dinitrophenyl)-4-(4-methoxyphenyl)-3-methyl-7-thioxo-7,8-
-dihydro-1H-pyrazolo4’,3’:5,6pyrido2,3-dpyrimidin-5-ylthiourea (6)
To a solution of 2 (0.01 mol) in acetic acid (15 mL), ammonium thiocyanate (0.03
mol) was added and the reaction mixture was refluxed for 10 h. The solid that separated
on cooling and dilution with water was filtered off and purified by boiling several times
with ethanol to give 6.
m.p. > 350 C. IR(KBr): max 3330 (NH) and 1620 (C=N) cm–1. Analysis for
C23H17N9O5S2 (%): calcd. C 49.02, H 3.02, N 22.38, S 11.37; found C 48.82, H 3.25, N





To a mixture of triethyl orthoformate (0.01 mol) and acetic anhydride (20 mL), com-
pound 2 or 3 (0.01 mol) was added and the reaction mixture was refluxed for 5 h. The
solvent was removed under reduced pressure and the separated solid was recrystallized
from butanol (products 7 and 10).
Compound 7. – m.p. 180 C. IR(KBr): max 2210 (CN) and 1618 (NH) cm–1. 1H NMR
(DMSO-d6), (ppm): 8.50 (1H, s, N=CH), 8.21–7.13 (7H, m, Ar-H), 4.60 (2H, q, OCH2CH3),
3.54 (3H, s, OCH3), 2.31 (3H, s, CH3), 1.26 (3H, t, OCH2CH3). Analysis for C24H19N7O6
(%): calcd. C 57.49, H 3.79, N 19.56; found C 57.79, H 4.02, N 19.48.
Compound 10. – m.p. 120 C. IR(KBr): max 2210 (CN) and 1610 (C=N) cm–1. Anal-





To a solution of 7 or 10 (0.01 mol) in absolute ethanol (50 mL), hydrazine hydrate
(0.01 mol) was added. The reaction mixture was refluxed for 2 h, concentrated, cooled,
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and the solid product that separated out was filtered off and recrystallized from ethanol
(products 8 and 11).
Compound 8. – m.p. 258 C. IR(KBr): max 3365 (NH2) and 1610 (C=N) cm–1. Analysis
for C22H17N9O5 (%): calcd. C 54.21, H 3.49, N, 25.87; found C 53.92, H 3.63, N 25.59.
Compound 11. – m.p. 158 C. IR(KBr): max 3370 (NH2) and 1615 (C=N) cm–1. 1H
NMR (DMSO-d6), (ppm): 9.62 (1H, s, N=CH), 8.00–7.38 (7H, m, ArH), 5.81 (1H, s, CH),
3.51 (3H, s, OCH3), 2.17 (3H, s, CH3). Analysis for C22H18N8O6 (%): calcd. C 53.88, H
3.67, N 22.86; found C 53.69, H 3.73, N 23.12.
Synthesis of 4-2-phenyldiazenyl-2-(2,4-dimitrophenyl)-5-methyl-2,4-dihydro-
-3H-pyrazol-3-one (13a) and 4-2-(4-chlorophenyl)diazenyl-2-(2,4-dinitrophenyl)-
-5-methyl-2,4-dihydro-3H-pyrazol-3-one (13b)
A mixture of 2,4-dinitrophenylhydrazine (0.01 mol) in ethanol (50 mL) ethyl 3-oxo-
-2-2-phenyldiazenylbutanoate (12a) or ethyl 2-(4-chlorophenyl)diazenyl-3-oxobuta-
noate (12b) (0.01 mol) was added and the reaction mixture was refluxed for 5 h. The
solid that separated on cooling was crystallized from ethanol (products 13a and 13b).
Compound 13a. – m.p. 168 C. IR(KBr): max 3321 (NH), 1647 (CO) and 1617 (C=N)
cm–1. Analysis for C16H12N6O5 (%): calcd. C 52.17, H 3.26, N 22.83; found C 52.32, H
3.18, N 22.96.
Compound 13b: m.p. 180 C. IR(KBr): max 3320 (NH), 1647 (CO) and 1614 (C=N)
cm–1. 1H NMR (DMSO-d6), (ppm): 8.82–7.66 (7H, m, Ar-H), 5.05 (1H, s, -CH pyrazo-
lone), 2.5 (3H, s, CH3). Analysis for C16H11ClN6O5 (%): calcd. C 47.70, H 2.73, N 20.87;
found C 47.89, H 2.78, N 21.12.
RESULTS AND DISCUSSION
The one-pot reaction of pyrazolone 1 with p-methoxybenzaldehyde, in the presence
of ammonium acetate afforded compound 2 through the adduct product of pyrazolone 1
and the first formed condensed product 2-(4-methoxybenzylidene)malononitrile follow-
ed by elimination of water and hydrogen. However, when the reaction was repeated in
the presence of piperidine, the pyranopyrazole derivative 3 was obtained. In further re-
actions, the bifunctional compound 2 was used for preparation of pyrazolo-pyrido-py-
rimidine derivatives. Thus, reaction of 2 with formic acid afforded compound 4. Treat-
ment of 2 with formamide in the presence of formic acid and dimethyl formamide gave
compound 5. On the other hand, heating of 2 with ammonium thiocyanate in boiling
acetic acid gave compound 6, while the reaction of 2 with triethyl orthoformate in boil-
ing acetic anhydride gave the pyrazolo pyridine derivative 7. Reaction of compound 7
with hydrazine hydrate gave the three fused ring 8.
The present investigation also involved the reaction of pyrazolone 1 with anisalde-
hyde and ethyl acetoacetate in the presence of ammonium acetate. This reaction affor-
ded pyrazolopyridine 9 through addition reaction, elimination of water, hydrogen and
decarboethoxylation. The syntheses of compounds 2–9 are outlined in Scheme 1.
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Reaction of 3 with triethyl orthoformate afforded compound 10. The structure of 10
was confirmed by its reaction with hydrazine hydrate to afford the pyrazolo pyranopy-
rimidine 11 (Scheme 2).
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Interestingly, the reaction of ethyl 3-oxo-2-2-phenyldiazenylbutanoate (12a) and
ethyl 2-2-(4-chlorophenyl)diazenyl-3-oxobutanoate (12b) with 2,4-dinitrophenylhydra-
zine in boiling ethanol afforded the pyrazolone derivatives 13a and 13b, respectively
(Scheme 3).
Antimicrobial activity of the prepared compounds 2–6, 8 and 11 was tested by the
disk diffusion method (14). Whatman No. 1 filter paper disks were sterilized by autocla-
ving for one hour at 140 C. The sterile disks were impregnated with the tested com-
pounds (250 g mL–1). Agar plates were uniformly surface inoculated with fresh broth
culture of Staphylococcus aureus and Bacillus cereus (as Gram positive strains), Serratia
marcescens and Proteus mirabilis (as Gram negative strains), Aspergillus fungytus (as
fungi). The impregnated disks were placed on the medium suitably spaced apart and
the plates were incubated at 5 °C for 1 h to permit good diffusion and were then trans-
ferred to an incubator at 28 °C for 24 h. The zones of inhibition were measured. The re-
sults of antimicrobial activity tests are listed in Table I. It is clear that compounds 5 and 6
possess high activity, while compounds 2–4, 8 and 11 possess moderate activity against
Gram positive strains.
As far as Gram negative microorganisms are concerned, compounds 4–6 and 11
showed high activity and compounds 2, 3 and 8 showed moderate activity.
Compounds 4–6 and 11 exerted moderate and compounds 2, 3 and 8 low activity
against fungi.
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Table I. Antimicrobial activity of some compoundsa,b
Compd.
No.
















2 ++ ++ ++ ++ +
3 +++ ++ +++ ++ +
4 +++ ++ +++ +++ ++
5 +++ +++ +++ +++ ++
6 +++ +++ +++ +++ ++
8 ++ +++ +++ ++ +
11 +++ ++ +++ +++ ++
a c = 250 g mL–1 (solvent: DMF)
b Reference substances: ampicillin for Gram positive and Gram negative bacteria, mycostatine for fungi.
+ Low activity (diameter 0.2–0.5 cm); ++ moderate activity (diameter 0.6–1.4 cm); +++ high activity (diameter
1.5–3.0 cm).
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S A @ E T A K
Sinteza nekih anuliranih derivata pirazolopirido (ili pirano) pirimidina,
pirazolopiridina i piranopirazola
SAIED ABDULLAH EL-ASSIERY, GALAL HOSNI SAYED* i AHMED FOUDA
Bifunkcionalni derivati pirazolopiridina (2) i piranopirazola (3) pripravljeni su reak-
cijom 2-(2,4-dinitrofenil)-5-metil-2,4-dihidro-3H-pirazol-3-ona (1) s p-metoksibenzalde-
hidom, malononitrilom u prisutnosti amonijevog acetata ili piperidina. Iz spoja 2 pri-
pravljeni su derivati pirazolopiridopirimidina reakcijom s mravljom kiselinom, smjesom
formamida-mravlje kiseline-DMF, amonijevim tiocijanatom ili s trietil-ortoformatom, te
naknadnom ciklizacijom s hidrazin hidratom. Reakcijom spoja 3 s trietil-ortoformatom
te cilklizacijom s hidrazin hidratom dobiveni su derivati pirazolo-pirano-pirimidina
(11). Reakcijom etil-3-okso-2-2-fenil-diazenilbutanoata i etil 2-2-(4-klorfenil)diazenil-
-3-oksobutanoata sa spojem 1 sintetizirani su derivati pirazolona 13a i 13b.
Klju~ne rije~i: derivati pirazolopiridina, derivati piranopirazola, sinteza
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